Drug General Information
Drug ID	D0U8ET
Former ID	DNC011165
Drug Name	3-(2-Bromophenyl)-6-methylcoumarin
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[531055]
Structure		Download 2D MOL 3D MOL
Formula	C16H11BrO2
Canonical SMILES	CC1=CC2=C(C=C1)OC(=O)C(=C2)C3=CC=CC=C3Br
InChI	1S/C16H11BrO2/c1-10-6-7-15-11(8-10)9-13(16(18)19-15)12-4-2-3-5-14(12)17/h2-9H,1H3
InChIKey	AEOXYENOHINSQF-UHFFFAOYSA-N
PubChem Compound ID	49864488
Target and Pathway
Target(s)	Amine oxidase [flavin-containing] B	Target Info	Inhibitor	[531055]
BioCyc Pathway	Superpathway of tryptophan utilization
	Tryptophan degradation via tryptamine
	Dopamine degradation
	Putrescine degradation III
	Noradrenaline and adrenaline degradation
KEGG Pathway	Glycine, serine and threonine metabolism
	Arginine and proline metabolism
	Histidine metabolism
	Tyrosine metabolism
	Phenylalanine metabolism
	Tryptophan metabolism
	Drug metabolism - cytochrome P450
	Metabolic pathways
	Serotonergic synapse
	Dopaminergic synapse
	Cocaine addiction
	Amphetamine addiction
	Alcoholism
PANTHER Pathway	Adrenaline and noradrenaline biosynthesis
	5-Hydroxytryptamine degredation
	Dopamine receptor mediated signaling pathway
Pathway Interaction Database	Alpha-synuclein signaling
WikiPathways	Tryptophan metabolism
	Dopamine metabolism
	Phase 1 - Functionalization of compounds
References
Ref 531055	Bioorg Med Chem Lett. 2010 Sep 1;20(17):5157-60. Epub 2010 Jul 8.New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors.
Ref 531055	Bioorg Med Chem Lett. 2010 Sep 1;20(17):5157-60. Epub 2010 Jul 8.New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.